Navigation Links
New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients
Date:5/9/2008

Phase III trial for ACTEMRA across multiple patient populations, it is an exciting day for RA patients, the science of RA and for Roche."

About the LITHE Trial

The LITHE trial is a three-arm, randomized, double-blind, placebo- controlled study designed to evaluate the safety and efficacy of ACTEMRA (4 mg/kg or 8 mg/kg) combined with methotrexate compared to placebo with methotrexate in RA patients. Patients received either ACTEMRA intravenously every four weeks plus methotrexate weekly or placebo infusions every four weeks plus methotrexate weekly.

The study analyzed patients' response to treatment by measuring structural damage in the joints through X-rays; disease activity was measured through standard assessments such as the ACR score(1), developed by the American College of Rheumatology (ACR). The study also examined improvement in physical function through the Health Assessment Questionnaire (HAQ).

The LITHE trial is one of five Phase III clinical studies designed to evaluate ACTEMRA as a potential new treatment for RA across multiple patient populations. Four of the Phase III trials - OPTION, TOWARD, RADIATE and AMBITION - are completed and have reported meeting their primary study endpoints. Data from all four trials will be presented at the upcoming European Congress of Rheumatology (ECR) held by the European League Against Rheumatism (EULAR) in Paris (June 11-14).

About ACTEMRA(TM) (tocilizumab)

ACTEMRA is the first humanized interleukin-6 (IL-6) receptor-inhibiting monoclonal antibody. Studies suggest that reducing the activity of IL-6, one of several key cytokines involved in the inflammatory process, may reduce inflammation of the joints and relieve certain systemic effects of RA. The extensive clinical development program conducted by Roche includes five clinical studies and has enrolled more than 4,000 patients in 40 countries, including the United States. Four studies are completed and have reported meeting th
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... -- Research and Markets  has announced the addition ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... monitor, and assess medical conditions, diseases, or infections usually ... earlier and more targeted treatment. These tests are minimally ... This kind of diagnostics provides early detection of diseases ...
(Date:7/22/2014)... , July 22, 2014 BiologicTx ® ... first 3-way Kidney Paired Donation transplant exchange ... procedures happened on July 9 at the Miami Transplant ... Miami, Fla. Kidney Paired ... are not compatible for kidney transplant with one another ...
(Date:7/22/2014)... , July 22, 2014  A central ... a SynCardia temporary Total Artificial Heart ... Strong Memorial Hospital with the Freedom® portable driver ... Fontana, a 64-year-old retiree from a Syracuse ... He managed the condition with medications, an implantable ...
Breaking Medicine Technology:Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... Calif., Feb. 24, 2011 Codexis, Inc. (Nasdaq: ... promoted to Chief Technology Officer and Senior Vice President, Process ... report to Alan Shaw, Ph.D., President and Chief Executive Officer. ... a 25-year career with DuPont. He served as Vice President, ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... ended December 31, 2010. For the fourth quarter ... $227 million and income from continuing operations of $17.6 million, ... million charge related to the settlement of litigation and changes ...
Cached Medicine Technology:Codexis Names David Anton CTO & SVP, Process Development & Manufacturing 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 3Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 4Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 5Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 6Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 7Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 8Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 9Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 10
(Date:7/22/2014)... (Boston)-- Researchers from Boston University School of Medicine ... that participants who received care through BMC,s Violence ... physical, mental, emotional and social needs of violently ... injuries and experienced life changing behaviors through connections ... feel trust and hope. These findings are reported ...
(Date:7/22/2014)... July 22, 2014 BlogHer, Inc. ... women, this year celebrates its tenth anniversary where it ... of attendees, including community leaders from the new women’s ... every consumer vertical, will converge in San Jose this ... and a “selfiebration” of social technology. , BlogHer’s ...
(Date:7/22/2014)... 22, 2014 New study findings released ... New Jersey’s patient-centered program is working to improve the ... study is the largest to date and includes more ... innovative approach that focuses on delivering better quality outcomes, ... care. , “Our most recent study results clearly ...
(Date:7/22/2014)... study by HIV researchers from Aarhus University and Aarhus ... drug can activate hidden HIV. The researchers found that ... HIV-infected cells between 2.1 and 3.9 times above normal ... to measurable levels in five out of six patients ... The results were presented today as breaking news at ...
(Date:7/22/2014)... CyraCom has been ranked as North America’s ... and interpreting industry. Released June 2014 by the market ... Language Services Market: 2014," also ranked CyraCom as the ... two spots from 2013. , In 2013, Common Sense ... interpretation services – a subset of the language service ...
Breaking Medicine News(10 mins):Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 2Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 3Health News:BlogHer, Inc. Comes Home to Silicon Valley for 10th Anniversary: World’s Largest Event for Bloggers and Social Media Influencers 4Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 2Health News:Horizon BCBSNJ’s 2013 Study Results Demonstrate Patient-centered Program Improves Patient Care and Lowers Costs 3Health News:Anti-cancer drug kicks HIV out of hiding 2Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2
... April 15 Couples looking for a relevant,approach ... find some no-nonsense,ideas when The Marriage Experience arrives ... groundbreaking event to the Oregon,Convention Center on its ... marriage education that promotes candid dialogue about,the real ...
... Other neurodegenerative, autoimmune diseases are more often cause, ... -- The root cause of early-onset dementia is ... or autoimmune disorder, new research suggests. , The ... the most common forms of dementia are Alzheimer,s ...
... Avalere Health today reminded,consumers to pay close attention ... including on which "tier" or group their,medications are ... show that an overwhelming majority of Medicare health,plans ... of the most expensive drugs,in newly created fourth ...
... Ability,to Meet Growing Demand for Care, AUSTIN, Texas, ... of Medicine,s (IOM) new report,"Retooling for an Aging America: ... (THCA) said the urgent need to expand the,state,s long ... care will,be severely undermined by the fact Texas, Medicaid ...
... Off Our Back(R) with Online ... Celebrity Shoe Auction, KENILWORTH, N.J., April ... one on the dance floor? DR. SCHOLL,S(R) FOR,HER and Julianne Hough, two-time ... partnered to raise money for,the charity foundation, Clothes Off Our Back(R). Starting ...
... be difficult. It also can be rewarding. In the ... important consequences for what students learn and what type ... culture can be accomplished without massive amounts of funding ... University School of Medicine. , A study published in ...
Cached Medicine News:Health News:Marriage for a New World 2Health News:Most Early-Onset Dementia Not Alzheimer's 2Health News:Most Early-Onset Dementia Not Alzheimer's 3Health News:Avalere Health Data Finds Four-Tier System Growing Among Medicare Part D Plans 2Health News:Texas Health Care Association: New Report on Long Term Care Workforce Spotlights Need to Boost Texas Medicaid Rates 2Health News:Video: Julianne Hough From Dancing With the Stars(TM) Has a New Partner: DR. SCHOLL'S(R) FOR HER 2Health News:Video: Julianne Hough From Dancing With the Stars(TM) Has a New Partner: DR. SCHOLL'S(R) FOR HER 3Health News:Cultural metamorphosis: Better doctors through better relationships 2Health News:Cultural metamorphosis: Better doctors through better relationships 3
Agarose L03 is recommended for separations of DNA fragments = 1,000 bp....
... Anion traces: chloride (Cl) ≤ 5000 mg/kg sulfate (SO ... 50 mg/kg Cd ≤ 5 mg/kg Co ≤ 5 ... Fe ≤ 10 mg/kg K ≤ 50 mg/kg Mg ... 2000 mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... flexible gels for separation of ... of wide range and standard ... mg/mL, clear, faintly yellow, hot ... MP: 90 °C (1% in ...
Medicine Products: